NF1

AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).

A Study of Avutometinib for People With Solid Tumor Cancers

Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1

Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas

Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1

Interventions for Reading Disabilities in NF1

Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1

A Phase II Trial of Poly-ICLC for Low-Grade Gliomas

FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas

Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1

Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults

A Study of INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1)

Study of Plexiform Neurofibromas in Neurofibromatosis Type 1

Adaptation and Quality of Life Among Adults With Neurofibromatosis Type I

Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas

Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas